Adults 18 to 64, any sex, with Chronic Pain or Musculoskeletal Diseases or Conditions. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change in Pain Disability Index (PDI) ScorePrimary· Baseline, Follow-up 4 weeks
PDI consists of 7 categories of life activity. The participant is asked to circle the number on the scale that describes the level of disability on typically experiences. A score of 0 means no disability at all, and a score of 10 signifies that all of the activities in which one would normally be involved have been totally disrupted or prevented by pain. The total range of score is 0-70; the higher the score, the greater the person's disability due to pain.
PCS is a 13-item self-report measure designed to assess catastrophic thinking related to pain among adults with or without chronic pain. Each item is rated on a 5-point Likert scale, from 0 (not at all) to 4 (all the time). The total range of score is 0-52; a higher score indicates a higher level of catastrophizing. A total score \>30 indicates clinically relevant level of catastrophizing.
Group
Value
95% CI
Pre-Training Arm (Control)
0
± 8
Post-Training Arm (Intervention)
1
± 7
Change in Hospital Anxiety and Depression Scale (HADS) ScoreSecondary· Baseline, Follow-up 4 weeks
HADS consists of two separate sub-sections: Anxiety and Depression. Each sub-section contains 7 items, where participants reply with responses that are closest to how he/she has been feeling in the past week with a score of 0-3. The total score range for both sub-sections is 0-21; a score of 0-7 indicates a "normal" range of anxiety, 8-10 = borderline abnormal, 11-21 = abnormal. The higher the score, the more abnormal the participant feels.
Group
Value
95% CI
Pre-Training Arm (Control)
-1
± 5
Post-Training Arm (Intervention)
0
± 5
Change in Fear Avoidance Beliefs Questionnaire (FABQ) ScoreSecondary· Baseline, Follow-up 4 weeks
FABQ is a self-reported questionnaire consisting of 16 questions scaled from 0-6. FABQ assesses the fear-avoidance beliefs of patients with chronic low back pain The total range of score is 0-96; a higher score indicates fear avoidance behaviors. For the purposes of this study, "I have a claim for compensation for my pain" will be excluded due to no relevance to the study.
PSEQ is a 10-item questionnaire developed to assess the confidence people with ongoing pain have in performing activities while in pain. The total range of score is 0-60; a higher score indicates greater levels of confidence in dealing with pain. High scores are strongly associated with clinically-significant functional levels.
Group
Value
95% CI
Pre-Training Arm (Control)
0
± 9
Post-Training Arm (Intervention)
0
± 13
MedRisk Instrument for Measuring Patient Satisfaction (MRPS) - Satisfaction With Process of Care ScoreSecondary· Follow-up 4 weeks
Satisfaction with process of care is measured by the "process of care" subscale of the MRPS. There are 8 items in this subscale scored on a Likert scale of 1-5. The total score range is 8-40; the higher the score, the greater the satisfaction.
Group
Value
95% CI
Pre-Training Arm (Control)
32
± 6
Post-Training Arm (Intervention)
32
± 6
Core Outcome Measures Index (COMI) - Satisfaction With the Outcome ScoreSecondary· Follow-up 4 weeks
Satisfaction with the outcome is measured by a single item derived from COMI: "If you had to spend the rest of life with the symptoms you have right now, how would you feel about it?". The total range of score is 0-10; the higher the score, the worse one feels about the outcome.
Group
Value
95% CI
Pre-Training Arm (Control)
1
1 – 2
Post-Training Arm (Intervention)
2
1 – 3
Sponsor's own description
The study objective is to establish feasibility of implementing a psychologically informed rehabilitation strategy while concurrently assessing its' effectiveness in Active duty service members (ADSM) with musculoskeletal disorders (MSD) seeking care in a US Navy shore-based healthcare setting. This intervention is intended to improve the management of chronic pain in order to optimize ADSM function.
The study team is proposing an observational prospective comparative cohort study. This study tests an implementation/strategy while observing/gathering information on the clinical intervention and related outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
Last refreshed: 11 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05132400.